Not Yet RecruitingNCT07469501
Comparing Outpatient Treatment Retention Among Individuals Using Fentanyl Randomized to Low-dose and Direct-to-inject Buprenorphine Initiation
Medication studyAges 18+United StatesAddiction
Understand this study
Who could participate?
Listed age limits: from 18 years.
- Listed locations
- San FranciscoSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateEstimated: June 2026
- Recruitment status
- Not Yet Recruiting
- Enrollment listed in the registry
- 50
- Sponsor
- University of California, San Francisco
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- Over 18 Years
- Official registry ID
- NCT07469501
- Official title
Show the full official title
Improving Buprenorphine Initiation Among Individuals With Opioid Use Disorder Using Fentanyl
Recruitment & locations
Not yet recruitingThis badge reflects the study status reported by the registry. Check the registry for the latest information.
San Francisco
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of California, San Francisco, a university.
Does this study involve medication?
Yes. The study involves medication, including Injectable buprenorphine and Sublingual Buprenorphine (SUBOXONE, Zubsolv, or generic tablets).
Who can participate?
Listed age limits: from 18 years.
Is this study still recruiting?
The registry lists this study as not yet recruiting.
